These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4549210)

  • 1. Von Wollebrand's disease with normal Factor VIII activity in a homozygote.
    Holmberg L; Rasović N; Nilsson IM
    Haemostasis; 1974; 3(4):237-46. PubMed ID: 4549210
    [No Abstract]   [Full Text] [Related]  

  • 2. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

  • 3. Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.
    Meyer D; Jenkins CS; Dreyfus MD; Fressinaud E; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):579-99. PubMed ID: 4549013
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Willebrand-factor activity and antigen in von Willebrand's disease.
    Meyer D; Jenkins CS; Dreyfus M; Larieu MJ
    Lancet; 1974 Mar; 1(7856):512-3. PubMed ID: 4131919
    [No Abstract]   [Full Text] [Related]  

  • 6. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Von Wollebrand's disease.
    Graham JB; Barrow ES
    Lancet; 1974 Mar; 1(7857):563. PubMed ID: 4132003
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Varieties of von Willebrand's disease.
    Peake IR; Bloom AL; Giddings JC
    Lancet; 1974 Jul; 2(7874):222-3. PubMed ID: 4135642
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH; Ekert H; Helliger H
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Von Willebrand factor and factor-viii-related antigen.
    Stableforth P; Barrowcliffe TW; Dormandy K
    Lancet; 1974 Apr; 1(7859):685. PubMed ID: 4132355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
    Mimaya J; Nagao T; Iizuka A; Yamashita H
    Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of heterozygotes for recessive von Willebrand's disease by the assay of antihemophilic-factor-like antigen.
    Veltkamp JJ; van Tilburg NH
    N Engl J Med; 1973 Oct; 289(17):882-5. PubMed ID: 4542316
    [No Abstract]   [Full Text] [Related]  

  • 14. Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation.
    Saba HI; Saba SR; Dent J; Ruggeri ZM; Zimmerman TS
    Blood; 1985 Aug; 66(2):282-6. PubMed ID: 3926021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Clotting factors in von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Bintadish P; Mannucci PM
    Lancet; 1974 Jul; 2(7872):105-6. PubMed ID: 4136883
    [No Abstract]   [Full Text] [Related]  

  • 18. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function.
    Ekert H; Ananthakrishnan R; Muntz RH; Dowling S; D'Souza S
    Thromb Haemost; 1976 Aug; 36(1):78-85. PubMed ID: 1087478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of Von Willebrand's syndrome (author's transl)].
    Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
    Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Clin Pathol; 1975 Apr; 28(4):309-16. PubMed ID: 805164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.